BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Since the original identification of the Philadelphia chromosome in 1959 [1] and the subsequent discovery of the BCR:ABL fusion [2] in chronic myelogenous leukemia, significant efforts have been aimed at identifying the causative genes driving cancer pathogenesis.